Citable company snapshot
Pfizer's latest SEC-sourced 2026-06-28 period shows $15.03B in revenue and $-248.00M in net income.
| Metric | Latest period | Latest value | Prior value | YoY |
|---|---|---|---|---|
| Revenue | Jun 28, 2026 | $15.03B | $14.45B | +4.0% |
| Net Income | Jun 28, 2026 | $-248.00M | $2.69B | -109.2% |
| Operating Cash Flow (computed) | Jun 28, 2026 | $835.00M | $2.62B | -68.1% |
| Free Cash Flow (computed) | Jun 28, 2026 | $302.00M | $2.18B | -86.1% |
Source: SEC EDGAR financial statements; period Jun 28, 2026; filed Aug 4, 2026; accession 0000078003-26-000095.
PFE company research is available with Aerarium Pro (CAD $10/mo). The five showcase tickers (TSLA, NVDA, AAPL, AMZN, PLTR) and the macro dashboard stay free. Already a subscriber? Sign in to pick up where you left off.